Cargando…
Effect of membrane-bound complement regulatory proteins on tumor cell sensitivity to complement-dependent cytolysis triggered by heterologous expression of the α-gal xenoantigen
Engineering malignant cells to express a heterologous α-gal antigen can induce heterograft hyperacute rejection, resulting in complement-dependent cytolysis (CDC) of tumor cells, which has been considered as a novel strategy for antitumor therapy. A549 cells engineered to express Galα1-3Galβ1-4GlcNA...
Autores principales: | Wang, Yu, Liao, Juan, Yang, Ya-Jun, Wang, Zhu, Qin, Feng, Zhu, Sheng-Ming, Zheng, Hong, Wang, Yan-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958734/ https://www.ncbi.nlm.nih.gov/pubmed/29805637 http://dx.doi.org/10.3892/ol.2018.8478 |
Ejemplares similares
-
Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis
por: Ge, Xiaowen, et al.
Publicado: (2021) -
Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum
por: Pipperger, Lisa, et al.
Publicado: (2019) -
The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
por: Geller, Anne, et al.
Publicado: (2019) -
Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by IgG antibody but not by target cell-bound C3
Publicado: (1975) -
Xenoantigen, an αGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line
por: Sawada, Tokihiko, et al.
Publicado: (2002)